assembly Bill A1673

2023-2024 Legislative Session

Requires health insurance policies and medicaid to cover biomarker testing for certain purposes

download bill text pdf

Sponsored By

Current Bill Status - In Assembly Committee


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (2)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
May 17, 2023 reported referred to ways and means
Jan 17, 2023 referred to insurance

Co-Sponsors

view additional co-sponsors

A1673 (ACTIVE) - Details

See Senate Version of this Bill:
S1196
Law Section:
Insurance Law
Laws Affected:
Amd §§3216, 3221 & 4303, Ins L; amd §365-a, Soc Serv L
Versions Introduced in 2021-2022 Legislative Session:
A9149, S8147

A1673 (ACTIVE) - Summary

Requires health insurance policies and medicaid to cover biomarker testing for diagnosis, treatment, appropriate management, or ongoing monitoring of a covered person's disease or condition when the test is supported by medical and scientific evidence.

A1673 (ACTIVE) - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   1673
 
                        2023-2024 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             January 17, 2023
                                ___________
 
 Introduced  by  M.  of  A.  HUNTER,  DINOWITZ,  BRONSON -- read once and
   referred to the Committee on Insurance
 
 AN ACT to amend the insurance  law  and  the  social  services  law,  in
   relation  to requiring health insurance policies and medicaid to cover
   biomarker testing for certain purposes

   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  Subsection  (i)  of  section 3216 of the insurance law is
 amended by adding a new paragraph 11-c to read as follows:
   (11-C) (A) EVERY POLICY WHICH  PROVIDES  MEDICAL,  MAJOR  MEDICAL,  OR
 SIMILAR COMPREHENSIVE-TYPE COVERAGE SHALL PROVIDE COVERAGE FOR BIOMARKER
 TESTING  FOR  THE  PURPOSES OF DIAGNOSIS, TREATMENT, APPROPRIATE MANAGE-
 MENT, OR ONGOING MONITORING OF A COVERED PERSON'S DISEASE  OR  CONDITION
 WHEN  THE  TEST IS SUPPORTED BY MEDICAL AND SCIENTIFIC EVIDENCE, INCLUD-
 ING, BUT NOT LIMITED TO:
   (I) LABELED INDICATIONS FOR A TEST APPROVED OR CLEARED BY THE FOOD AND
 DRUG ADMINISTRATION OF THE UNITED STATES GOVERNMENT OR  INDICATED  TESTS
 FOR A FOOD AND DRUG ADMINISTRATION APPROVED DRUG;
   (II)  CENTERS  FOR  MEDICARE  AND  MEDICAID SERVICES NATIONAL COVERAGE
 DETERMINATIONS AND MEDICARE  ADMINISTRATIVE  CONTRACTOR  LOCAL  COVERAGE
 DETERMINATIONS; OR
   (III) NATIONALLY RECOGNIZED CLINICAL PRACTICE GUIDELINES AND CONSENSUS
 STATEMENTS.
   (B)  SUCH  COVERAGE  SHALL  BE  PROVIDED  IN A MANNER THAT SHALL LIMIT
 DISRUPTIONS IN CARE INCLUDING THE NEED FOR MULTIPLE BIOPSIES OR  BIOSPE-
 CIMEN SAMPLES.
   (C)  THE COVERED PERSON AND PRESCRIBING PRACTITIONER SHALL HAVE ACCESS
 TO A CLEAR, READILY ACCESSIBLE, AND CONVENIENT  PROCESS  TO  REQUEST  AN
 EXCEPTION  TO  A  COVERAGE POLICY PROVIDED PURSUANT TO THE PROVISIONS OF
 THIS PARAGRAPH. SUCH PROCESS SHALL BE MADE  READILY  ACCESSIBLE  ON  THE
 WEBSITE OF THE INSURER.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD02625-01-3